Haemonetics (HAE) has redrawn its business map by merging its Plasma and Blood Center units into a single Apheresis segment ...

Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 4:00 PM EDTCompany ParticipantsChristopher Simon ...

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced an update to its reportable ...

Detailed price information for Haemonetics Corp (HAE-N) from The Globe and Mail including charting and trades.

Detailed price information for Haemonetics Corp (HAE-N) from The Globe and Mail including charting and trades.

Haemonetics gains attention after softer earnings highlighted the impact of unusual accounting items and long-term healthcare ...

Fintel reports that on May 22, 2026, B of A Securities upgraded their outlook for Haemonetics (NYSE:HAE) from Neutral to Buy. Analyst Price Forecast Suggests 35.40% Upside As of May 14, 2026, the ...

9 analysts have shared their evaluations of Haemonetics (NYSE:HAE) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their recent ...

Haemonetics Corp. has announced it has completed the acquisition of the business assets of Pall Corp.’s blood collection, filtration and processing product lines, according to a news release. The ...

Haemonetics stock (NYSE: HAE), best known for its blood and plasma supplies and services, has fallen by 3.5% in the last week, while it is down 7% over the last ten days. HAE stock has been on a ...